<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=217082&amp;fmt=gif">

MD Biosciences Blog

Pig post operative pain model pioneered by our scientists recognized in a scientific publication: Synergistic Effect of Bupivacaine and Meloxicam in Clinical & Animal Studies

Posted by MD Biosciences

on Jul 12, 2018 10:45:29 AM

Proud to announce that the pig post operative pain model pioneered by our scientists was used and cited in a clinical study poster publication written by Heron Therapeutics to assess the synergistic effect of Bupivacaine and Meloxicam in HTX-011.

"Meloxicam and Bupivacaine combined in a single extended-release formulation (HTX-011) delivered at the wound site in a preclinical post-surgical pain model in pigs exhibited greater analgesia than either compound delivered alone within the same extended-release formulation; this finding was confirmed in an initial clinical trial in bunionectomy" (Heron Therapeutics, 2018).

To learn more about our rodent and pig post-operative pain models, visit our preclinical pain webpage or view  our datasheet below.

pig post-operative pain (POP) model, preclinical efficacy 

Topics: preclinical research, neuropathic pain, post-operative pain, Pain